Bicycle Therapeutics Plc - ADR
NASDAQ:BCYC
Market Cap (Intraday) | 1.75B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $24.97 |
50-Day MA | $23.45 |
200-Day MA | $21.81 |
Bicycle Therapeutics Plc - ADR Stock, NASDAQ:BCYC
Granta Park Great Abington, Portway Building, Cambridge, Cambridgeshire CB21 6GS
United Kingdom
Phone: +44.1223.261503
Number of Employees: 284
Description
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.